Join industry titans, homegrown innovators, and post-secondary leaders as we address the challenges hindering our region's $27.4B life sciences sector and explore opportunities and solutions to catalyze growth, elevate economic contributions, and advance health outcomes.
About the event
With $27.4B in GDP contributions, 89K employees, and $1.2B in pharma-related R&D, the life sciences sector in Ontario has a strong strategic and economic presence. However, despite the sector’s strengths, the Toronto region is lagging relative to our peer jurisdictions. Held back by the inability to commercialize, scale, or economically benefit directly from our own innovation, products or services, our life sciences economy and health outcomes will fall short.
The Life Sciences Symposium is a forum for open dialogue and discussion to unpack Toronto region's life science sector and catalyze its growth. This half-day event will draw on the insights and expertise of a range of players in the ecosystem, including established multinationals, fast-growing home-grown companies, post-secondary institutions, and innovators.
Join us for an engaging program that will help you better understand the sector's challenges, how to leverage opportunities for your business, and its potential to contribute to economic growth, innovation, and good jobs in the Toronto Region and better health outcomes for Canadians.
Check-in and network with other guests before our event begins.
- Giles Gherson, President & CEO, Toronto Region Board of Trade
The province has set a goal to maintain and grow Ontario’s biomanufacturing and life sciences sector by targeting 85,000 high-value jobs in the life sciences sector by 2030, a 25% increase from 2020. These opening remarks will provide insights into Ontario’s life sciences strategy and progress made in building out Ontario’s industry to become a leader in the life sciences sector.
- The Hon. Minister Victor Fedeli, Minister of Economic Development, Job Creation and Trade, Government of Ontario
Enjoy a delectable meal from our venue partners, Oliver & Bonacini.
Why attend? Join us for an exclusive session featuring an international luminary from a thriving life sciences cluster. Gain invaluable insights as they delve into the powerful lessons and learnings gleaned from global jurisdictions, specifically tailored to elevate Toronto's standing. Don't miss this unique opportunity to tap into a wealth of knowledge that could help inform the future of life sciences in our region.
- Travis McCready, Head of Life Sciences, Americas Markets Chair, Global Life Sciences Advisory Board, JLL
While the region has strong research and innovation capacities, the sector struggles to commercialize at scale – limiting the economic benefit derived from innovative ideas, products, and services developed by the region’s life sciences sector.
Why attend? A clearer path to commercialization, with fewer barriers, is critical to growth in this sector. In this session, you will hear from key members in the life sciences ecosystem discuss how we can turn breakthrough innovations into successful commercial products while improving healthcare outcomes.
- Jason Fields, President and CEO, Life Sciences Ontario
- Arthur Kesisyan, VP Life Sciences Canada, AtkinsRéalis
Breakout #1 – Building Capacity: Investing in Infrastructure & Real Estate
Toronto has Canada’s largest life sciences sector, but it’s running out of room to grow. Institutions in the region are looking for an estimated 3.5 million square feet of lab space that doesn’t exist. We aren’t sufficiently planning for the space companies will need to grow. This includes wet labs, training centres and more.
Why attend? The session will likely address the critical issue of space constraints in Toronto's life sciences sector. If you’re a life sciences professional, this will explore solutions to help overcome growth challenges, expand your ability to expand operations and develop new products.
Breakout #2 – Harnessing Our Workforce
An additional 14,300 workers will be needed in bio-health and bio-industrial industries by 2029 to meet hiring requirements in the Greater Toronto Area, including:
- 9000 workers in bio-health
- 4100 workers in bio-industrial
- 670 workers in agri-bio
- 390 workers in bio-energy
According to Bio-Talent Canada, new talent pools will be important because domestic enrolments in bio-economy-related post-secondary programs are expected to decrease in the coming years.
Why attend? This session will unpack the need for highly skilled professionals to catalyze growth and ensure success for the life sciences sector. Panelists in this session will explore talent gaps – ranging from executive management to technical expertise. It will also address how we can build on our existing talent base to meet the growing needs of the sector and help our companies compete globally.
Breakout #3 – Unleashing the MedTech Cluster
- There are 30,200 people working in Ontario’s MedTech sector at almost 1,300 companies that collectively earn $18.7 billion in revenues annually.
- Ontario’s MedTech sector has attracted global players like Medtronic, GE Healthcare, Stryker, and Johnson & Johnson.
Why attend? As the epicenter of innovation and growth — and attracting global players — the Toronto region's MedTech cluster is set to soar to unprecedented heights. Join us as we unravel the untapped potential within this dynamic ecosystem, navigate the barriers and discover the keys to unlocking unparalleled opportunities. With the 2024 MedTech conference on the horizon, this is your chance to gain invaluable insights from visionaries shaping the future of healthcare technology and position yourself to benefit from these opportunities.
Ontario is responsible for 51% of Canada's R&D funding and personnel, empowering a robust innovation ecosystem. Cutting-edge innovations are happening right in our background, supported by public sector investments to bring these innovations to the world.
Why should you attend? Join us for a chance to hear about leading made-in-Ontario health care solutions. Learn how they are using advanced technologies to solve complex challenges, create new opportunities, and improve lives.
- Jeremy Grushcow, Co-Founder and CEO, Juniper Genomics
- Chris Bass, Co-Founder, and CEO, InventoRR MD
- Chenny Xia, Co-Founder and CEO, Gotcare
Format: Two contestants from local life sciences companies will face off in a Jeopardy-style game show with a series of questions under various themes.
Why attend? Don’t miss this exciting, interactive show. Watch as contestants will tackle questions focused on key challenges, barriers and tangible solutions in our region’s life science sector.
- Giles Gherson, President & CEO of Toronto Region Board of Trade
- Member: $149
- Non-Member: $229
Table of 10:
- Member: $1,490
- Non-Member: $2,290